Treating renal artery stenosis. A statement pro endovascular therapy
Martin Schillinger1, Erich Minar, Ramazanali Ahmadi
1Division of Angiology, Department of Internal Medicine II, Vienna General Hospital, Medical School, Vienna, Austria. martin.schillinger@akh-wien.ac.at
Abstract:
Renal artery stenosis (RAS) leading to hypertension or ischemic nephropathy can be treated by endovascular revascularization using balloon angioplasty or stent implantation. Although high technical success rates > 95%, relatively low frequencies of complications and good long-term patency can be achieved, the indications for interventional treatment are a matter of ongoing debate. Curing hypertension by means of angioplasty rarely occurs, although the number of antihypertensive medication usually can be reduced after successful treatment. Targeting ischemic nephropathy, revascularization can stabilize or at least slow the decline of renal function. Nevertheless, angioplasty also bears the risk of inducing renal deterioration. Careful patient selection remains the most crucial point in renal interventions, however, current data are insufficient to give final recommendations on this issue. The present review focuses on the potential beneficial effects of renal artery PTA and stenting in patients with RAS.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Aneurysm III: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Imaging Studies VII: Vascular Imaging
Aortic Regurgitation III: Medical Management
